Cargando…

Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China

We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside...

Descripción completa

Detalles Bibliográficos
Autores principales: Boldog, Péter, Tekeli, Tamás, Vizi, Zsolt, Dénes, Attila, Bartha, Ferenc A., Röst, Gergely
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/
https://www.ncbi.nlm.nih.gov/pubmed/32093043
http://dx.doi.org/10.3390/jcm9020571
_version_ 1783506681318080512
author Boldog, Péter
Tekeli, Tamás
Vizi, Zsolt
Dénes, Attila
Bartha, Ferenc A.
Röst, Gergely
author_facet Boldog, Péter
Tekeli, Tamás
Vizi, Zsolt
Dénes, Attila
Bartha, Ferenc A.
Röst, Gergely
author_sort Boldog, Péter
collection PubMed
description We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number [Formula: see text]). We found that in countries with low connectivity to China but with relatively high [Formula: see text] , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low [Formula: see text] benefit the most from policies that further reduce [Formula: see text]. Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing.
format Online
Article
Text
id pubmed-7073711
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70737112020-03-19 Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China Boldog, Péter Tekeli, Tamás Vizi, Zsolt Dénes, Attila Bartha, Ferenc A. Röst, Gergely J Clin Med Article We developed a computational tool to assess the risks of novel coronavirus outbreaks outside of China. We estimate the dependence of the risk of a major outbreak in a country from imported cases on key parameters such as: (i) the evolution of the cumulative number of cases in mainland China outside the closed areas; (ii) the connectivity of the destination country with China, including baseline travel frequencies, the effect of travel restrictions, and the efficacy of entry screening at destination; and (iii) the efficacy of control measures in the destination country (expressed by the local reproduction number [Formula: see text]). We found that in countries with low connectivity to China but with relatively high [Formula: see text] , the most beneficial control measure to reduce the risk of outbreaks is a further reduction in their importation number either by entry screening or travel restrictions. Countries with high connectivity but low [Formula: see text] benefit the most from policies that further reduce [Formula: see text]. Countries in the middle should consider a combination of such policies. Risk assessments were illustrated for selected groups of countries from America, Asia, and Europe. We investigated how their risks depend on those parameters, and how the risk is increasing in time as the number of cases in China is growing. MDPI 2020-02-19 /pmc/articles/PMC7073711/ /pubmed/32093043 http://dx.doi.org/10.3390/jcm9020571 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Boldog, Péter
Tekeli, Tamás
Vizi, Zsolt
Dénes, Attila
Bartha, Ferenc A.
Röst, Gergely
Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title_full Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title_fullStr Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title_full_unstemmed Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title_short Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China
title_sort risk assessment of novel coronavirus covid-19 outbreaks outside china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073711/
https://www.ncbi.nlm.nih.gov/pubmed/32093043
http://dx.doi.org/10.3390/jcm9020571
work_keys_str_mv AT boldogpeter riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina
AT tekelitamas riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina
AT vizizsolt riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina
AT denesattila riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina
AT barthaferenca riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina
AT rostgergely riskassessmentofnovelcoronaviruscovid19outbreaksoutsidechina